The glucoregulatory actions of GLP-1RAs are well known and include glucose-dependent stimulation of insulin secretion and inhibition of glucagon release, resulting in a marked reduction in HbA1c in people with type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.